The hepatitis B virus (HBV) and polyomavirus (Py) enhancer regions contain multiple cis-acting elements that contribute to enhancer activity. The EF-C binding site was previously shown to be an important functional component of each enhancer region. EF-C is a ubiquitous binding activity that interacts with an inverted repeat sequence in the HBV and Py enhancer regions. Although the EF-C binding site is required for optimal enhancer function, the EF-C site does not possess intrinsic enhancer activity when assayed in the absence of flanking elements. With both the HBV and Py enhancer regions, EF-C stimulates the activity of adjacent enhancer elements in a synergistic manner. EF-C corresponds to RFX-1, a protein that binds to a conserved and functionally important site in major histocompatibility complex (MHC) class II antigen promoter regions. Interestingly, the RFX-1 binding site in MHC class II promoters only contains an EF-C half-site, maintaining one arm of the inverted repeat in an EF-C binding site. We have investigated the binding of purified EF-C and RFX-1 to sites in the Py and HBV enhancer regions that carry mutations that either disrupt one arm of the EF-C inverted repeat, or alter the spacing between the repeats. Our results show that the interaction of EF-C and RFX-1 with an intact inverted repeat is required for functional activity of these viral enhancer regions. Chemical footprinting and modification interference assays show that the interaction of EF-C and RFX-1 with the DRA MHC class II promoter truly represents half-site interaction, and that this binding is unstable. In contrast, the binding of EF-C and RFX-1 to the viral inverted repeats is stable. These results suggest that an additional activity may be required to stabilize EF-C/RFX-1 interaction with the MHC class II promoter, and that viral enhancer regions have evolved high affinity binding sites to sequester dimeric EF-C/RFX-1.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				Y. Lubelsky, N. Reuven, and Y. Shaul Autorepression of Rfx1 Gene Expression: Functional Conservation from Yeast to Humans in Response to DNA Replication Arrest Mol. Cell. Biol., December 1, 2005; 25(23): 10665 - 10673. [Abstract] [Full Text] [PDF]

				R. Tierney, H. Kirby, J. Nagra, A. Rickinson, and A. Bell The Epstein-Barr Virus Promoter Initiating B-Cell Transformation Is Activated by RFX Proteins and the B-Cell-Specific Activator Protein BSAP/Pax5 J. Virol., November 15, 2000; 74(22): 10458 - 10467. [Abstract] [Full Text]

				E. K. Schmitt and U. Kuck The Fungal CPCR1 Protein, Which Binds Specifically to beta -Lactam Biosynthesis Genes, Is Related to Human Regulatory Factor X Transcription Factors J. Biol. Chem., March 24, 2000; 275(13): 9348 - 9357. [Abstract] [Full Text] [PDF]

				Y. Katan-Khaykovich and Y. Shaul RFX1, a Single DNA-binding Protein with a Split Dimerization Domain, Generates Alternative Complexes J. Biol. Chem., September 18, 1998; 273(38): 24504 - 24512. [Abstract] [Full Text] [PDF]

				K. Roder, S. S. Wolf, K.-F. Beck, and M. Schweizer Cooperative Binding of NF-Y and Sp1 at the DNase I-hypersensitive Site, Fatty Acid Synthase Insulin-responsive Element 1, Located at -500 in the Rat Fatty Acid Synthase Promoter J. Biol. Chem., August 22, 1997; 272(34): 21616 - 21624. [Abstract] [Full Text] [PDF]

				S. Habib and S. E. Hasnain A 38-kDa Host Factor Interacts with Functionally Important Motifs within the Autographa californica Multinucleocapsid Nuclear Polyhedrosis Virus Homologous Region (hr1) DNA Sequence J. Biol. Chem., November 8, 1996; 271(45): 28250 - 28258. [Abstract] [Full Text] [PDF]